Pharmacodynamic assessment of ertapenem (MK-0826) against Streptococcus pneumoniae in a murine neutropenic thigh infection model.
about
Pharmacodynamic profile of ertapenem against Klebsiella pneumoniae and Escherichia coli in a murine thigh modelPharmacokinetics and tolerability of single-dose intravenous ertapenem in infants, children, and adolescentsComparative pharmacokinetics and pharmacodynamic target attainment of ertapenem in normal-weight, obese, and extremely obese adultsActivity of carbapenems combined with clavulanate against murine tuberculosis.Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh modelUse of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies.Ertapenem: review of a new carbapenem.Murine models of pneumococcal pneumonia and their applicability to the study of tissue-directed antimicrobials.Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice.Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection modelA Critical Review of Analytical Methods for Determination of Ertapenem Sodium.The capsule of Streptococcus pneumoniae contributes to virulence in the insect model Manduca sexta.Population pharmacokinetics of ertapenem in juvenile and old rats.
P2860
Q33555094-4D8C74BA-C9C8-446F-8424-44CF738493E7Q34348830-ABFCDF0A-9BBE-4991-AD9D-BBD8C72F6753Q34510697-467FF67B-A360-45D3-A88C-4823D491FB0EQ35004912-D233CFFB-2645-4A0E-AA09-BABFD40FDF62Q35758849-54AE1F03-9CC6-413C-9C7A-AEB1F9363D44Q36018937-D0913FDC-52F7-4C9B-8191-835989228D2BQ36066200-A4595DE6-E07D-4217-BD71-2E1DD09F7C26Q36320604-05D7FBB3-D2BF-4299-8DA1-9DEE6CDF1A31Q36719706-451BA4C9-CAB0-480B-9FAC-FD4F48423C3EQ37036574-532086D5-900E-45C2-8D2E-4E4E10545C0DQ38726679-C974B9D2-5951-477F-80B4-5AC3354094FEQ42010631-068BB0FC-694E-4984-8246-74E44AE07632Q42264085-2F1058E7-DC6A-43B4-B5B2-591E55227C53
P2860
Pharmacodynamic assessment of ertapenem (MK-0826) against Streptococcus pneumoniae in a murine neutropenic thigh infection model.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pharmacodynamic assessment of ...... ropenic thigh infection model.
@ast
Pharmacodynamic assessment of ...... ropenic thigh infection model.
@en
Pharmacodynamic assessment of ertapenem
@nl
type
label
Pharmacodynamic assessment of ...... ropenic thigh infection model.
@ast
Pharmacodynamic assessment of ...... ropenic thigh infection model.
@en
Pharmacodynamic assessment of ertapenem
@nl
prefLabel
Pharmacodynamic assessment of ...... ropenic thigh infection model.
@ast
Pharmacodynamic assessment of ...... ropenic thigh infection model.
@en
Pharmacodynamic assessment of ertapenem
@nl
P2093
P2860
P1476
Pharmacodynamic assessment of ...... ropenic thigh infection model.
@en
P2093
Blair Capitano
Charles Nightingale
David Nicolau
Dawei Xuan
Maryanne Banevicius
Myo-Kyoung Kim
P2860
P304
P356
10.1128/AAC.46.9.2990-2995.2002
P407
P577
2002-09-01T00:00:00Z